Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-03-05 @ 9:50 AM
Study NCT ID:
NCT05241067
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-17
First Post:
2022-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Sponsor:
Pharmazz, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Centhaquine/ARDS /CT-2.2/2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None